Presentation
Association of Survival and Progression-Free Survival with Immune Response in HLA-A2+ Newly- Diagnosed GBM Patients in Randomized Double-Blind Placebo-Controlled Phase 2 Trial of Dentritic Cell (DC) Immunotherapy with ICT-107
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures
Event Name/Location
The 20th Annual Scientific Meeting and Education Day for the Society for Neuro-Oncology; 2015 November 19-22; San Antonio, TX
Document Type
Conference Presentation
Publication Date
11-1-2015
Disciplines
Citation Information
Patrick Wen, David Reardon, Surasak Phuphanich, Robert Aiken, et al.. "Association of Survival and Progression-Free Survival with Immune Response in HLA-A2+ Newly- Diagnosed GBM Patients in Randomized Double-Blind Placebo-Controlled Phase 2 Trial of Dentritic Cell (DC) Immunotherapy with ICT-107" (2015) Available at: http://works.bepress.com/radleigh-santos/6/